Small Scale Bioreactors Market find out Growth Potential through Demand Forecast 2030

Bioreactors are bioprocessing devices that are used for biochemical processing that involves biological active substances and micro-organisms. This bioprocessing can be aerobic or anaerobic. The various type of bioreactors are designed as cylindrical structures and come in different sizes and capacities with various materials such as glass bioreactors, carbon steel, stainless steel bioreactors, ceramic bioreactors, and Polytetrafluoroethylene (PTFE) plastic. Bioreactors can be used in vaccine production for static culture or roller bottle technology. During the production process, bioreactors provide sterile gas such as oxygen and carbon dioxide into the culture medium. The constant stirring distributes the nutrients and reduces the size of gas bubbles that arise due to the sterile gas supply in the culture vessel, thus releasing oxygen into the nutrient solution. The pharmaceutical industry’s increased efforts to create vaccines or medications is expected to drive the growth of the market. For instance, according to the India Brand Equity Foundation (IBEF), between April 2020 and June 2021, the foreign direct investment (FDI) into the Indian pharmaceutical industry totaled at US$ 18.12 billion.

Market players are indulged in research and development activities which is expected to increase the growth of the global small scale bioreactors market over the forecast period. For instance, according to article published in the journal Frontiers in Bioengineering and Biotechnology, August 2020, researchers of University College of London, U.K. conducted the study to review Small-Scale Fluidized Bed Bioreactor (sFBB) for Long-Term Dynamic Culture of 3D Cell Constructs and in vitro Testing. The results of the study demonstrated that sFBB serve as a device for long-term culture and analysis of 3D cell constructs with prospects of engineering in vitro models, which could more closely reproduce the in vivo conditions and in a more cost-effective manner, and ultimately contribute towards reducing the use of animal models in research.

Increasing number of inorganic growth strategies such as collaborations of key players in the regions such as North America, Europe, and Asia pacific is expected to drive the growth of small scale bioreactors market over the forecast period. For instance, in August 2020, Pluristem Therapeutics Inc., a regenerative medicine company, announced that its subsidiary, Pluristem Ltd., had signed a non-binding Memorandum of Understanding (MOU) with the United Arab Emirates-based Abu Dhabi Stem Cells Center (ADSCC), a specialist healthcare center focused on cell therapy and regenerative medicine. Under this collaboration, the company and the healthcare center will work for the development of cell therapies and regenerative medicines for the treatment of severe diseases including COVID-19.

The constraints and challenges for bioreactors during biological processing may hamper the growth of the small scale bioreactors market over the forecast period. For instance, the current tendency in biopharmaceutical manufacturing to create a tailored plant to the specific bioprocessing requirements of a given molecule, there are processing restrictions, such as non-customizable bioreactors. Molecules, on the other hand, do not behave the same way during the development, scale-up, and manufacturing phases. Customizing single use bioreactors to process specific molecules negates bioreactor’s main advantage of automatic configuration and Disposal Single use bioreactors are frequently made from plastic derivatives such as Appliflex ST which is fully customized bioreactor designed for specific bioprocessing needs by Applikon biotechnology In addition to concerns about potential leachable and extractable materials, the large-scale disposal of such plastic reactors on a regular basis is an environmental concern.